Lori Y. Kam

2.9k total citations
27 papers, 2.2k citations indexed

About

Lori Y. Kam is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lori Y. Kam has authored 27 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 8 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lori Y. Kam's work include Inflammatory Bowel Disease (23 papers), Microscopic Colitis (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Lori Y. Kam is often cited by papers focused on Inflammatory Bowel Disease (23 papers), Microscopic Colitis (7 papers) and Acute Lymphoblastic Leukemia research (6 papers). Lori Y. Kam collaborates with scholars based in United States, Canada and Belgium. Lori Y. Kam's co-authors include Stephan R. Targan, Eric A. Vasiliauskas, María T. Abreu, Philip V. Hassard, Fabio Cominelli, Theresa T. Pizarro, Huiying Yang, Vincenzo Casini–Raggi, Marla C. Dubinsky and Ernest G. Seidman and has published in prestigious journals such as The Journal of Immunology, Gastroenterology and The American Journal of Gastroenterology.

In The Last Decade

Lori Y. Kam

27 papers receiving 2.2k citations

Peers

Lori Y. Kam

GENET

EPIDE

IMMUN

SURGE

PHEOH

Gottfried Novacek Austria

Alexander Teml Austria

S. B. Hanauer United States

Joaquín Hinojosa Spain

Julia Seiderer Germany

Ian C. Lawrance Australia

Stephen J. Bickston United States

Marcus Harbord United Kingdom

Kenneth R. Falchuk United States

Julien Kirchgesner France

Gottfried Novacek Austria

Lori Y. Kam

1.8k ×1.4

GENET

1.6k ×1.8

EPIDE

387 ×0.7

IMMUN

1.2k ×2.3

SURGE

354 ×0.8

PHEOH

Citations per year, relative to Lori Y. Kam Lori Y. Kam (= 1×) peers Gottfried Novacek

Countries citing papers authored by Lori Y. Kam

Since Specialization

Citations

This map shows the geographic impact of Lori Y. Kam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Y. Kam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Y. Kam more than expected).

Fields of papers citing papers by Lori Y. Kam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Y. Kam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Y. Kam. The network helps show where Lori Y. Kam may publish in the future.

Co-authorship network of co-authors of Lori Y. Kam

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Y. Kam. A scholar is included among the top collaborators of Lori Y. Kam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Y. Kam. Lori Y. Kam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hassard, Philip V., Eric A. Vasiliauskas, Lori Y. Kam, Stephan R. Targan, & María T. Abreu. (2007). Efficacy of mycophenolate mofetil in patients failing 6-mercaptopurine or azathioprine therapy for Crohn's disease. Inflammatory Bowel Diseases. 6(1). 16–20. 13 indexed citations

Abreu, María T., Jordan L. Geller, Eric A. Vasiliauskas, et al.. (2005). Treatment With Infliximab Is Associated With Increased Markers of Bone Formation in Patients With Crohn's Disease. Journal of Clinical Gastroenterology. 40(1). 55–63. 67 indexed citations

Seidner, Douglas L., Bret A. Lashner, Aaron Brzezinski, et al.. (2005). An oral supplement enriched with fish oil, soluble fiber, and antioxidants for corticosteroid sparing in ulcerative colitis: A randomized, controlled trial. Clinical Gastroenterology and Hepatology. 3(4). 358–369. 88 indexed citations

Dubinsky, Marla C., Huiying Yang, Philip V. Hassard, et al.. (2002). 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease. Gastroenterology. 122(4). 904–915. 380 indexed citations

Abreu, María T., Kent D. Taylor, Ying–Chao Lin, et al.. (2002). Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. Gastroenterology. 123(3). 679–688. 333 indexed citations

Abreu, María T., Scott W. Binder, Konstantinos Papadakis, et al.. (2001). Malignancy following remicadeTM therapy: Incidence and characteristics. Gastroenterology. 120(5). A619–A619. 14 indexed citations

Dubinsky, Marla C., Philip V. Hassard, Ernest G. Seidman, et al.. (2001). An Open-Label Pilot Study Using Thioguanine as a Therapeutic Alternative in Crohn's Disease Patients Resistant to 6-Mercaptopurine Therapy. Inflammatory Bowel Diseases. 7(3). 181–189. 112 indexed citations

Tung, Jeanne, Scott W. Binder, Lori Y. Kam, et al.. (2001). Outcome of cytomegalovirus infections in patients with inflammatory bowel disease. The American Journal of Gastroenterology. 96(7). 2137–2142. 194 indexed citations

Kam, Lori Y. & Stephan R. Targan. (2000). TNF-α antagonists for the treatment of Crohn’s disease. Expert Opinion on Pharmacotherapy. 1(4). 615–622. 33 indexed citations

10.

Hassard, Philip V., Eric A. Vasiliauskas, Lori Y. Kam, Stephan R. Targan, & María T. Abreu. (2000). Efficacy of Mycophenolate Mofetil in Patients Failing 6-Mercaptopurine or Azathioprine Therapy for Crohnʼs Disease. Inflammatory Bowel Diseases. 6(1). 16–20. 36 indexed citations

11.

Dubinsky, Marla C., Philip V. Hassard, María T. Abreu, et al.. (2000). Thioguanine (6-TG): A therapeutic alternative in a subgroup of IBD patients failing 6-mercaptopurine (6-MP). Gastroenterology. 118(4). A891–A891. 5 indexed citations

12.

Kam, Lori Y. & Stephan R. Targan. (1999). Cytokine-based therapies in inflammatory bowel disease. Current Opinion in Gastroenterology. 15(4). 302–302. 18 indexed citations

13.

Plevy, Scott E., Eric Vasiliauskas, Lori Y. Kam, et al.. (1999). Crohn's disease-associated genetic marker is seen in medically unresponsive ulcerative colitis patients and may be associated with pouch-specific complications. Diseases of the Colon & Rectum. 42(5). 601–605. 20 indexed citations

14.

Vasiliauskas, Eric A., Lori Y. Kam, Maria T. Abreu-Martin, et al.. (1999). An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease. Gastroenterology. 117(6). 1278–1287. 208 indexed citations

15.

Tountas, Nikolaos, Vincenzo Casini–Raggi, Huiying Yang, et al.. (1999). Functional and ethnic association of allele 2 of the interleukin-1 receptor antagonist gene in ulcerative colitis. Gastroenterology. 117(4). 806–813. 166 indexed citations

16.

Kam, Lori Y.. (1998). Ulcerative colitis in young adults. Postgraduate Medicine. 103(1). 45–59. 1 indexed citations

17.

Liebman, Howard A., et al.. (1998). The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease. Gastroenterology. 115(4). 830–834. 78 indexed citations

18.

Kam, Lori Y., et al.. (1996). A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults.. PubMed. 91(7). 1338–42. 45 indexed citations

19.

Casini–Raggi, Vincenzo, et al.. (1995). Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.. The Journal of Immunology. 154(5). 2434–2440. 335 indexed citations

20.

Kam, Lori Y., Theresa T. Pizarro, & Fabio Cominelli. (1995). Cytokines and chemokines in inflammatory bowel disease. Current Opinion in Gastroenterology. 11(4). 305–309. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact